毕得医药: 第二届监事会第十八次会议决议公告

Group 1 - The company held its 18th meeting of the second Supervisory Board on July 15, 2025, with all three supervisors present, ensuring compliance with relevant laws and regulations [1][2] - The Supervisory Board decided to abolish the Supervisory Board and transfer its powers to the Audit Committee of the Board of Directors, in accordance with the new Company Law and the revised Guidelines for Listed Companies [1][2] - The company plans to modify its business scope and amend relevant provisions in its Articles of Association to reflect these changes [1] Group 2 - The company proposed to reappoint Zhonghui Certified Public Accountants as the financial report auditor and internal control auditor for the fiscal year 2025, with audit fees to be negotiated based on market principles [2] - The resolution regarding the reappointment of the auditing firm received unanimous approval from all supervisors and will be submitted to the shareholders' meeting for further consideration [2]